Article citationsMore>>

Abou-Alfa, G.K., Lau, G., Kudo, M., et al. (2022) Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma. Journal of Clinical Oncology, 40, 336-345.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top